We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $214M
1-Year Est. Return 18.82%
This Fund
S&P 500
This Quarter Est. Return
+0.07%
1 Year Est. Return
+18.82%
3 Year Est. Return
+59.8%
5 Year Est. Return
+72.92%
10 Year Est. Return
+638.85%
AUM
$214M
AUM Growth
+$2.36M
Cap. Flow
+$4.45M
Cap. Flow %
2.08%
Top 10 Hldgs %
45.39%
Holding
532
New
48
Increased
61
Reduced
124
Closed
49

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$429K
2
AMZN icon
Amazon
AMZN
+$425K
3
GILD icon
Gilead Sciences
GILD
+$390K
4
COR icon
Cencora
COR
+$295K
5
SPGI icon
S&P Global
SPGI
+$258K

Sector Composition

Rank Sector Weight
1 Technology 5.94%
2 Industrials 2.22%
3 Communication Services 2.06%
4 Financials 1.77%
5 Consumer Discretionary 1.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZM icon
451
Zoom
ZM
$26.7B
$643 ﹤0.01%
8
LUMN icon
452
Lumen
LUMN
$6.45B
$639 ﹤0.01%
92
VSTS icon
453
Vestis
VSTS
$2.03B
$629 ﹤0.01%
+80
New +$584
PACS icon
454
PACS Group
PACS
$7.45B
$610 ﹤0.01%
+19
New +$699
PPLI
455
People Inc
PPLI
$3.15B
$600 ﹤0.01%
15
SBH icon
456
Sally Beauty Holdings
SBH
$1.43B
$582 ﹤0.01%
42
-5,258
-99% -$80.2K
IHRT icon
457
iHeartMedia
IHRT
$547M
$581 ﹤0.01%
+199
New +$659
DBI icon
458
Designer Brands
DBI
$298M
$575 ﹤0.01%
101
ARVN icon
459
Arvinas
ARVN
$530M
$562 ﹤0.01%
+53
New +$656
LEG icon
460
Leggett & Platt
LEG
$1.5B
$553 ﹤0.01%
+56
New +$639
VNDA icon
461
Vanda Pharmaceuticals
VNDA
$314M
$546 ﹤0.01%
+79
New +$609
WOOF icon
462
Petco
WOOF
$777M
$545 ﹤0.01%
+196
New +$542
CNO icon
463
CNO Financial Group
CNO
$4.96B
$534 ﹤0.01%
+13
New +$543
PLX icon
464
Protalix BioTherapeutics
PLX
$193M
$512 ﹤0.01%
+236
New +$586
RXT icon
465
Rackspace Technology
RXT
$980M
$358 ﹤0.01%
+365
New +$444
BEAM icon
466
Beam Therapeutics
BEAM
$2.58B
$357 ﹤0.01%
15
CERS icon
467
Cerus
CERS
$615M
$349 ﹤0.01%
192
SSYS icon
468
Stratasys
SSYS
$700M
$312 ﹤0.01%
40
PATH icon
469
UiPath
PATH
$6.02B
$311 ﹤0.01%
28
MTLS
470
Materialise
MTLS
$373M
$262 ﹤0.01%
53
TXG icon
471
10x Genomics
TXG
$5.83B
$255 ﹤0.01%
12
U icon
472
Unity
U
$13.3B
$219 ﹤0.01%
10
PD icon
473
PagerDuty
PD
$753M
$199 ﹤0.01%
32
NTLA icon
474
Intellia Therapeutics
NTLA
$1.49B
$154 ﹤0.01%
12
PACB icon
475
Pacific Biosciences
PACB
$422M
$127 ﹤0.01%
96

Similar funds

C.M. Bidwell & Associates's Q1 2026 Portfolio in Review

As of Q1 2026, C.M. Bidwell & Associates held 532 positions worth $214M, up 1.1% from $212M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

C.M. Bidwell & Associates's Q1 2026 filing shows 48 new, 61 increased, 124 reduced and 49 closed positions. Its largest new stake was Broadcom: 1,309 shares worth $405K. The largest sale was Boston Scientific, an estimated $429K.

By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.3% a quarter earlier, followed by Industrials and Communication Services.

  • C.M. Bidwell & Associates's largest Q1 2026 buy was Broadcom: 1,309 shares worth $405K.
  • C.M. Bidwell & Associates added most to Schwab Short-Term US Treasury ETF in Q1 2026, an estimated $1.63M increase.
  • C.M. Bidwell & Associates's biggest Q1 2026 reduction was Amazon, cutting an estimated $425K.
  • C.M. Bidwell & Associates fully exited Boston Scientific in Q1 2026, selling an estimated $429K.
  • C.M. Bidwell & Associates's ten largest holdings make up 45% of its $214M portfolio in Q1 2026.
  • C.M. Bidwell & Associates opened 48 new positions and closed 49 in Q1 2026.
  • C.M. Bidwell & Associates's portfolio value rose 1.1% quarter-over-quarter to $214M.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.